NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Microbio Co. Ltd (TWO: 4128)

 
4128 Technical Analysis
1
As on 9th Jun 2023 4128 STOCK Price closed @ 60.70 and we RECOMMEND N/A for LONG-TERM with Stoploss of 0.00 & N/A for SHORT-TERM with Stoploss of 0.00 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

4128STOCK Price

Open 59.90 Change Price %
High 61.00 1 Day N/A N/A
Low 59.90 1 Week 0.00 0.00
Close 60.70 1 Month 0.00 0.00
Volume 1900267 1 Year 0.00 0.00
52 Week High 0.00 | 52 Week Low 0.00
 
TWO Taiwan Most Active Stocks
6125 44.70 %
4533 18.00 %
4979 76.40 %
6122 44.45 %
5425 102.00 %
8358 63.30 %
3374 128.00 %
2743 162.50 %
8069 227.00 %
1815 13.95 %
 
TWO Taiwan Top Gainers Stocks
5306 172.00 3.30%
8438 38.40 1.99%
1752 39.55 0.25%
1752 39.55 0.25%
 
TWO Taiwan Top Losers Stocks
3652 22.55 -0.88%
 
 
4128
Daily Charts
4128
Intraday Charts
Whats New @
Bazaartrend
4128
Free Analysis
 
4128 Important Levels Intraday
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
 
4128 Forecast October 2023
4th UP Forecast0
3rd UP Forecast0
2nd UP Forecast0
1st UP Forecast0
1st DOWN Forecast0
2nd DOWN Forecast0
3rd DOWN Forecast0
4th DOWN Forecast0
 
4128 Weekly Forecast
4th UP Forecast0.00
3rd UP Forecast0.00
2nd UP Forecast0.00
1st UP Forecast0.00
1st DOWN Forecast0.00
2nd DOWN Forecast0.00
3rd DOWN Forecast0.00
4th DOWN Forecast0.00
 
4128 Forecast2023
4th UP Forecast0
3rd UP Forecast0
2nd UP Forecast0
1st UP Forecast0
1st DOWN Forecast0
2nd DOWN Forecast0
3rd DOWN Forecast0
4th DOWN Forecast0
 
Microbio Co. Ltd ( TWO Taiwan Symbol : 4128 )
Sector : Healthcare And Other Stocks in Same Sector
 
4128 Other Details
Segment EQ
Market Capital 27185917952.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
4128 Address
4128
 
4128 Latest News
 
Your Comments and Response on Microbio Co. Ltd
 
4128 Business Profile
Microbio Co., Ltd. develops and sells various therapeutics in Taiwan. It offers nutritional supplements, skin care products, and organic agricultural products. The company also provides MS-20 for ameliorating fatigue and appetite loss associated with cancer chemotherapy; and Herbiron, which reveals symptoms of iron deficiency anemia and menstrual discomfort. Its pre-clinical stage products include SNS01, SNA02, and SNA-03 to treat various types of cancers, as well as SNA-07 for cancer immune therapy; and SNP-630 to treat non-alcoholic steatohepatitis. The company's Phase I clinical trial products consist of OB-318, an anti-cancer drug; MB-110 for the treatment of hepatitis C; SNP-810, an acetaminophen; FB317 to treat moderate-to-severe allergic asthma and chronic idiopathic urticaria; and FB704A for the treatment of rheumatoid arthritis, cancer, and cytokine storms. In addition, it offers FB825, which is in Phase II clinical trial for the treatment of atopic dermatitis, allergic asthma, hyper IgE syndrome, and food allergy. Additionally, the company's Phase III clinical trial products comprise ON101 to treat diabetic foot ulcer; and MB-6 that acts as an adjuvant for metastatic colorectal cancer. Further, the company's discovery stage pipeline includes FB121 for AIDS; SNA01 to treat PD-1 related cancer; SNA02 for cancer immune therapy; and SNS01 for recurrent metastatic non-small cell lung cancer. Microbio Co., Ltd. was founded in 2000 and is based in Taipei, Taiwan. Address: No.3,Yuan Qu Street, Taipei, Taiwan, 115
 
2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service